Binding to Programmed death-ligand 1 (PD-L1) expressed on tumour cells blocks the ability to downregulate cluster of differentiation 8 (CD-8)+ T-cells, increasing the immunogenic activity within the tumour microenvironment, and leading to cytotoxic effects on tumour cells. The gene discussed is CD8A; the disease is neoplasm.